Skip to content

Author

Christopher R. Flowers

We have 3 of 19 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Developing Effective, Evidence-Based Training for Cancer Team Science Leadership for National Impact.

A 2025 National Academies' report, The Science and Practice of Team Science, identified critical gaps in leadership development and highlighted evidence-based best practices and infrastructure needs to enhance team science. This brief perspective addresses team science approaches needed to overcome the complexities of...

Christopher R. Flowers, Shi-Ne Chang, HwaYoung Lee et al. · 0 citations
Open access Jul 2026

Clinical utility of real-time comprehensive molecular testing in large B-cell lymphoma.

The clinical utility and acceptable TAT of a comprehensive WES and RNA-seq assay for LBCL managed in routine clinical practice are demonstrated and support the real-world feasibility of using integrated WES and RNA-seq to define molecular subgroups, guide clinical decision-making at the time of a new line of therapy, a...

Dai Chihara, Kumudha Balakrishnan, G. Masand et al. · 0 citations
Open access Aug 2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

This White Paper written by the Global Lymphoma Registry Alliance (LyRA) discusses the importance and value of lymphoma registries for different stakeholders as well as benefits of forming a global alliance of the registry network.

Eliza A. Hawkes, E. Chung, M. Bishton et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.